v3.25.2
Business and Principal Activities (Details Narrative)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended 18 Months Ended
Feb. 10, 2025
USD ($)
$ / shares
shares
Apr. 11, 2024
USD ($)
Investor
$ / shares
shares
Jan. 26, 2024
USD ($)
Investor
$ / shares
shares
Apr. 03, 2023
USD ($)
shares
Nov. 10, 2022
USD ($)
Jun. 30, 2025
USD ($)
$ / shares
Mar. 31, 2025
USD ($)
Jun. 30, 2024
USD ($)
shares
Mar. 31, 2024
USD ($)
shares
Jun. 30, 2025
USD ($)
$ / shares
Jun. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
$ / shares
Dec. 31, 2024
USD ($)
$ / shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Proceeds from sale of equity                       $ 71,400  
Net proceeds from sale of equity                       64,300  
Cash and cash equivalents           $ 12,314       $ 12,314   $ 12,314 $ 7,154
Common stock, par value | $ / shares           $ 0.0001       $ 0.0001   $ 0.0001 $ 0.0001
Accumulated deficit           $ 55,534       $ 55,534   $ 55,534 $ 50,219
Net loss           2,895 $ 2,420 $ 2,389 $ 1,076 $ 5,315 $ 3,465    
Maximum possible proceeds from offerings         $ 50,000                
Registered Direct Offering [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Sale of shares | shares       1,557,632                  
Gross proceeds from offering       $ 5,000                  
Net proceeds from public offering       4,300                  
Placement agent fees       400                  
Professional expenses       $ 300                  
Registered Direct Offering [Member] | April 2023 Warrant [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants to purchase common stock | shares       1,947,040                  
Private Placement [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants exercise price | $ / shares   $ 1.69                      
Warrants to purchase common stock | shares   701,243                      
Net proceeds from public offering   $ 9,600                      
Number of accredited investors | Investor   172 92                    
Gross proceeds   $ 11,100 $ 6,100                    
Other Expenses   $ 200 $ 700                    
Number of common stock issued | shares     6,133,414                    
Warrant term   5 years 5 years                    
Placement agent fees   $ 1,300                      
Private Placement [Member] | January 2024 PA Warrants [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants exercise price | $ / shares     $ 0.99                    
Warrants to purchase common stock | shares     511,940                    
Warrant term     5 years                    
Private Placement [Member] | January 2024 PA Warrants [Member] | Management [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants exercise price | $ / shares     $ 1.22                    
January 2024 Common Warrants [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants to purchase common stock | shares     6,133,414                    
Underwritten Public Offering [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Sale of shares | shares 11,523,810                        
Warrants to purchase common stock | shares 576,191                        
Net proceeds from public offering $ 10,800                        
Professional expenses 500                        
Gross proceeds $ 12,100                        
Warrant term 5 years                        
Underwriting fees $ 800                        
Share price per shrare | $ / shares $ 1.21                        
Common Stock [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Net loss                  
Warrants exercise price | $ / shares           $ 10.80       $ 10.80   $ 10.80  
Number of common stock issued | shares               6,960,864 6,133,414        
Common Stock [Member] | Private Placement [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants to purchase common stock | shares   951,500                      
Number of common stock issued | shares   6,960,864                      
Prefunded Common Stock Warrants [Member] | Private Placement [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants exercise price | $ / shares   $ 0.0001                      
Series A Warrants [Member] | Private Placement [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants exercise price | $ / shares   $ 1.22                      
Warrants to purchase common stock | shares   7,912,364                      
Warrant term   5 years                      
Series B Warrants [Member] | Private Placement [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants exercise price | $ / shares   $ 1.22                      
Warrants to purchase common stock | shares   3,956,182                      
Warrant term   2 years